Skip to main content
. 2020 Dec 1;17:101. doi: 10.1186/s12986-020-00528-x

Fig. 2.

Fig. 2

Linear trend of IBS-SSS in compliant and non-compliant subjects. In C subjects the reduction trend was maintained and significant both between baseline and week 6, and between week 3 and week 6. In NC subjects the reduction was significant only between baseline and week 6, but between week 3 and week 6 there was no difference. In fact, a “symptom rebound” could be seen in some subjects